Literature DB >> 19506139

Stability of the Clinical Dementia Rating, 1979-2007.

Monique M Williams1, Catherine M Roe, John C Morris.   

Abstract

OBJECTIVE: To examine dementia severity as determined by the Clinical Dementia Rating (CDR) over time.
DESIGN: Secondary analysis of data from longitudinal studies of aging and dementia.
SETTING: Alzheimer's Disease Research Center, where a variety of clinicians contributed CDR ratings during the study. PARTICIPANTS: Adults aged 63 to 83 years with no (CDR 0), very mild (CDR 0.5), or mild (CDR 1) dementia enrolled in the Alzheimer's Disease Research Center at any time from August 13, 1979, through May 30, 2007. MAIN OUTCOME MEASURES: Within each CDR group, changes in scores on standardized psychometric tests with time were examined using multiple linear regression analyses. These tests included the Mini-Mental State Examination, Short Blessed Test, Logical Memory IA-Immediate from the Wechsler Memory Scale-Revised, and Blessed Dementia Scale, and a psychometric composite score.
RESULTS: A total of 1768 participants met the inclusion criteria. With time, participants were older, more educated, and more likely to be nonwhite and less likely to be men. Statistically significant change in psychometric test performance with time occurred only within the CDR 1 group for Logical Memory and the psychometric composite, but the degree of change was minimal.
CONCLUSION: Despite changes in participant characteristics, the CDR demonstrates general stability for assessment of dementia for almost 3 decades.

Entities:  

Mesh:

Year:  2009        PMID: 19506139      PMCID: PMC2779108          DOI: 10.1001/archneurol.2009.69

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.

Authors:  Martha Storandt; Elizabeth A Grant; J Philip Miller; John C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

3.  Reliability of the Washington University Clinical Dementia Rating.

Authors:  W J Burke; J P Miller; E H Rubin; J C Morris; L A Coben; J Duchek; I G Wittels; L Berg
Journal:  Arch Neurol       Date:  1988-01

4.  Validation of clinical diagnostic criteria for Alzheimer's disease.

Authors:  J C Morris; D W McKeel; K Fulling; R M Torack; L Berg
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

5.  Speed functions, vocabulary ability, and age.

Authors:  J Botwinick; M Storandt
Journal:  Percept Mot Skills       Date:  1973-06

6.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

7.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

8.  Mild cognitive impairment represents early-stage Alzheimer disease.

Authors:  J C Morris; M Storandt; J P Miller; D W McKeel; J L Price; E H Rubin; L Berg
Journal:  Arch Neurol       Date:  2001-03

9.  Interrater reliability of the Clinical Dementia Rating in a multicenter trial.

Authors:  K Rockwood; D Strang; C MacKnight; R Downer; J C Morris
Journal:  J Am Geriatr Soc       Date:  2000-05       Impact factor: 5.562

10.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Authors:  R Katzman; T Brown; P Fuld; A Peck; R Schechter; H Schimmel
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

View more
  18 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  The Movement Disorders Society criteria for the diagnosis of Parkinson's disease dementia: their usefulness and limitations in elderly patients.

Authors:  Michèle Kiesmann; Jean-Baptiste Chanson; Julien Godet; Thomas Vogel; Laetitia Schweiger; Saïd Chayer; Georges Kaltenbach
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

3.  Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.

Authors:  Catherine M Roe; Anne M Fagan; Elizabeth A Grant; Daniel S Marcus; Tammie L S Benzinger; Mark A Mintun; David M Holtzman; John C Morris
Journal:  Arch Neurol       Date:  2011-09

4.  Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time.

Authors:  Kathleen M Hayden; Richard N Jones; Catherine Zimmer; Brenda L Plassman; Jeffrey N Browndyke; Carl Pieper; Lauren H Warren; Kathleen A Welsh-Bohmer
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

5.  Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers.

Authors:  Catherine M Roe; Beau M Ances; Denise Head; Ganesh M Babulal; Sarah H Stout; Elizabeth A Grant; Jason Hassenstab; Chengjie Xiong; David M Holtzman; Tammie L S Benzinger; Suzanne E Schindler; Anne M Fagan; John C Morris
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

6.  Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.

Authors:  Hege Kersten; Espen Molden; Tiril Willumsen; Knut Engedal; Torgeir Bruun Wyller
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  Choosing Alzheimer's disease prevention clinical trial populations.

Authors:  Joshua D Grill; Sarah E Monsell
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

8.  Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers.

Authors:  Sarah H Stout; Ganesh M Babulal; Chunyu Ma; David B Carr; Denise M Head; Elizabeth A Grant; Monique M Williams; David M Holtzman; Anne M Fagan; John C Morris; Catherine M Roe
Journal:  Alzheimers Dement       Date:  2018-01-10       Impact factor: 21.566

9.  Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease.

Authors:  C M Roe; A M Fagan; M M Williams; N Ghoshal; M Aeschleman; E A Grant; D S Marcus; M A Mintun; D M Holtzman; J C Morris
Journal:  Neurology       Date:  2011-01-12       Impact factor: 9.910

Review 10.  Modeling cognitive trajectories within longitudinal studies: a focus on older adults.

Authors:  Joshua R Steinerman; Charles B Hall; Martin J Sliwinski; Richard B Lipton
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.